Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Kayla K. Lemmon

MTORC1/2 Inhibition as a Therapeutic Strategy for PIK3CA Mutant Cancers

Molecular Cancer Therapeutics

Cancer Research

English

Related publications

mTORC1 Inhibition Is Required for Sensitivity to PI3K P110 Inhibitors in PIK3CA-Mutant Breast Cancer

Science Translational Medicine

English

Dual Inhibition of PI3K and mTORC1/2 Signaling by NVP-BEZ235 as a New Therapeutic Strategy for Acute Myeloid Leukemia

Clinical Cancer Research

Cancer Research

English

Substrate-Selective COX-2 Inhibition as a Novel Strategy for Therapeutic Endocannabinoid Augmentation

Trends in Pharmacological Sciences

English

DDR1 Inhibition as a New Therapeutic Strategy for Colorectal Cancer

Molecular and Cellular Oncology

Cancer Research

Molecular Medicine

English

Inhibition of the BCR-Abl Tyrosine Kinase as a Therapeutic Strategy for CML

Cancer Research

Molecular Biology

English

RAD001 Offers a Therapeutic Intervention Through Inhibition of mTOR as a Potential Strategy for Esophageal Cancer

Oncology Reports

Cancer Research

English

Inhibition of 12/15-Lipoxygenase as Therapeutic Strategy to Treat Stroke

Annals of Neurology

English

Combined PPARg Activation and XIAP Inhibition as a Potential Therapeutic Strategy for Ovarian Granulosa Cell Tumors

Molecular Cancer Therapeutics

Cancer Research

English

A Landscape of Therapeutic Cooperativity in KRAS Mutant Cancers Reveals Principles for Controlling Tumor Evolution

Molecular Biology

English